StockData
Bright Minds Biosciences Inc. logo

Bright Minds Biosciences Inc. (DRUG) stock

DRUGNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 40-F on Dec 23, 2025Score 5/30
$20.76+0.25 (+1.22%)

Close on Nov 18, 2026Market cap $158.52MP/E –Yield –

Bright Minds Biosciences total assets

Total assets on the balance sheet at the end of each period.

Bright Minds Biosciences's total assets was C$84.42M at Sep 30, 2025. For fiscal 2025 it was C$84.42M, up 1282.9% from the year before. The highest annual figure on record is C$84.42M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Sep 30, 2025C$84.42M+1282.9%
FY2024Sep 30, 2024C$6.10M-11.3%
FY2023Sep 30, 2023C$6.88M-43.1%
FY2022Sep 30, 2022C$12.09M-39.7%
FY2021Sep 30, 2021C$20.04M+2176.8%
FY2020Sep 30, 2020C$880.22K–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2025CQ3 2025Sep 30, 2025C$84.42M+321.3%
Q4 FY2024CQ3 2024Sep 30, 2024C$6.10M+593.5%
Q4 FY2023CQ3 2023Sep 30, 2023C$6.88M–
Q4 FY2022CQ3 2022Sep 30, 2022C$12.09M–
Q4 FY2021CQ3 2021Sep 30, 2021C$20.04M–
Q4 FY2020CQ3 2020Sep 30, 2020C$880.22K–

More Bright Minds Biosciences figures

See a number that looks wrong?